pimobendan has been researched along with beraprost in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajimoto, K; Kasanuki, H; Kawai, A; Matsuda, N; Naganuma, M; Shiga, T; Watanabe, E | 1 |
1 other study(ies) available for pimobendan and beraprost
| Article | Year |
|---|---|
Low-dose systemic phosphodiesterase III inhibitor pimobendan combined with prostacyclin therapy in a patient with severe primary pulmonary hypertension.
Topics: Adult; Drug Therapy, Combination; Epoprostenol; Female; Heart Failure; Humans; Hypertension, Pulmonary; Phosphodiesterase Inhibitors; Prostaglandins I; Pyridazines | 2003 |